β-Trcp couples β-catenin phosphorylation-degradation and regulates Xenopus axis formation

  1. Chunming Liu,
  2. Yoichi Kato,
  3. Zhuohua Zhang,
  4. Viet Minh Do,
  5. Bruce A. Yankner, and
  6. Xi He*
  1. Division of Neuroscience, Children’s Hospital, Department of Neurology, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115
  1. Communicated by Harold E. Varmus, National Institutes of Health, Bethesda, MD (received for review March 1, 1999)

Abstract

Regulation of β-catenin stability is essential for Wnt signal transduction during development and tumorigenesis. It is well known that serine-phosphorylation of β-catenin by the Axin–glycogen synthase kinase (GSK)–3β complex targets β-catenin for ubiquitination–degradation, and mutations at critical phosphoserine residues stabilize β-catenin and cause human cancers. How β-catenin phosphorylation results in its degradation is undefined. Here we show that phosphorylated β-catenin is specifically recognized by β-Trcp, an F-box/WD40-repeat protein that also associates with Skp1, an essential component of the ubiquitination apparatus. β-catenin harboring mutations at the critical phosphoserine residues escapes recognition by β-Trcp, thus providing a molecular explanation for why these mutations cause β-catenin accumulation that leads to cancer. Inhibition of endogenous β-Trcp function by a dominant negative mutant stabilizes β-catenin, activates Wnt/β-catenin signaling, and induces axis formation in Xenopus embryos. Therefore, β-Trcp plays a central role in recruiting phosphorylated β-catenin for degradation and in dorsoventral patterning of the Xenopus embryo.

Footnotes

  • * To whom reprint requests should be addressed at: Children’s Hospital, En-379, 300 Longwood Avenue, Boston, MA 02115. e-mail: he_x{at}hub.tch.harvard.edu.

  • ABBREVIATION:
    GST,
    glutathione S-transferase;
    GSK,
    glycogen synthase kinase;
    TCF,
    T cell factor
« Previous | Next Article »Table of Contents